Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus

Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus

<i>Background:</i> Patients with diabetes mellitus (DM) are known to show poor recovery after stroke. This specific burden might be due to acute and chronic hyperglycemic effects. Meanwhile, the underlying mechanisms are a cause of discussion, and the best measure to predict the outcome...

Full description

Bibliographic Details
Main Authors: Alexandra Filipov, Heike Fuchshuber, Josephine Kraus, Anne D. Ebert, Vesile Sandikci, Angelika Alonso
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
stroke outcome
diabetes mellitus
hyperglycemia
skin autofluorescence
advanced glycation end products
poststroke complications
Online Access:https://www.mdpi.com/2077-0383/11/6/1625

Internet

https://www.mdpi.com/2077-0383/11/6/1625

Similar Items